Study on the Molecular Prevalence and Genotypic Distribution of Torque Teno Virus in Iranian Hemodialysis Patients
BioMed Research International · 2025
DOI: 10.1155/bmri/2504873 ↗Kurz gefasst
Fachartikel in der Zeitschrift BioMed Research International, 2025. Verfasst von Amin Naseri und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, CTC, Islamic Azad University, Tehran, Iran. Hauptthemen laut MEDLINE: Torque teno virus, Renal Dialysis, DNA Virus Infections. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This case‐control study investigated the prevalence, genotypic distribution, and associated factors of Torque Teno Virus (TTV) infection in a cohort of 1576 hemodialysis (HD) patients compared to 1000 healthy individuals in Iran. This study is aimed at assessing the epidemiological profile of TTV, while also exploring its relationship with coinfections and various demographic factors, given the unclear clinical significance of TTV. Nested PCR and sequencing techniques were utilized to identify TTV DNA and its genotypes. The prevalence of TTV was significantly higher in patients undergoing HD, at 51.8%, compared to just 11.5% in healthy individuals. Coinfections were also notable, with 16.8% of HCV‐positive, 5.3% of HBV‐positive, and 3.0% of HIV‐positive HD patients also carrying TTV. Genotypic analysis revealed distinct distributions: Genotypes 3, 17, 11, and 13 were more common in HD patients, while Genotypes 1, 3, and 17 were more prevalent in controls. Additionally, there was a significant correlation between advanced age and longer dialysis duration with TTV positivity. Variations in TTV prevalence across different studies emphasize the influence of methodological and geographical factors, underscoring the need for standardized diagnostic approaches. While the pathogenicity of TTV remains unclear, its potential as an indicator of immune compromise or coinfection risk warrants further investigation. This study highlights the need for enhanced monitoring in HD units to reduce transmission and stresses the importance of long‐term research to clarify TTV’s clinical significance. The findings emphasize the need for tailored infection control measures for high‐risk groups, particularly in regions with a higher prevalence of HCV/HBV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology, CTC, Islamic Azad University, Tehran, Iran.
- Department of Physiology, School of Medicine, Ilam University of Medical Science, Ilam, Iran.
- Department of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran.
- Microbiology Research Center (MRC), Pasteur Institute of Iran, Tehran, Iran.
ORCID-Profile: Amin Naseri, Enayat Anvari, Seyyedeh Masumeh Mirnurollahi, Abolfazl Fateh
Zitieren
APA
Naseri, A., Anvari, E., Mirnurollahi, S. M., & Fateh, A. (2025). Study on the Molecular Prevalence and Genotypic Distribution of Torque Teno Virus in Iranian Hemodialysis Patients. BioMed Research International. https://doi.org/10.1155/bmri/2504873
Vancouver
Naseri A, Anvari E, Mirnurollahi SM, Fateh A. Study on the Molecular Prevalence and Genotypic Distribution of Torque Teno Virus in Iranian Hemodialysis Patients. BioMed Research International. 2025. doi:10.1155/bmri/2504873
BibTeX
@article{Naseri2025,
author = {Naseri, Amin and Anvari, Enayat and Mirnurollahi, Seyyedeh Masumeh and Fateh, Abolfazl},
title = {Study on the Molecular Prevalence and Genotypic Distribution of Torque Teno Virus in Iranian Hemodialysis Patients},
journal = {BioMed Research International},
year = {2025},
doi = {10.1155/bmri/2504873}
}
EUVIMED